Financhill
Buy
59

ADUS Quote, Financials, Valuation and Earnings

Last price:
$129.80
Seasonality move :
3.51%
Day range:
$126.14 - $132.55
52-week range:
$85.94 - $136.12
Dividend yield:
0%
P/E ratio:
30.07x
P/S ratio:
1.95x
P/B ratio:
2.51x
Volume:
458.8K
Avg. volume:
152.3K
1-year change:
38.81%
Market cap:
$2.4B
Revenue:
$1.1B
EPS (TTM):
$4.37

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ADUS
Addus HomeCare
$289.5M $1.28 1.35% 12.56% $137.82
AMED
Amedisys
$588.8M $1.17 4.55% 80.17% --
DGX
Quest Diagnostics
$2.4B $2.26 12.75% 28.89% $169.77
OPCH
Option Care Health
$1.2B $0.32 12.91% 6.29% --
OPRX
OptimizeRx
$25M $0.06 4.13% -69.17% $10.36
RHE
Regional Health Properties
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ADUS
Addus HomeCare
$131.40 $137.82 $2.4B 30.07x $0.00 0% 1.95x
AMED
Amedisys
$84.49 -- $2.8B 33.53x $0.00 0% 1.20x
DGX
Quest Diagnostics
$153.10 $169.77 $17.1B 20.58x $0.75 1.93% 1.80x
OPCH
Option Care Health
$22.91 -- $3.9B 19.25x $0.00 0% 0.84x
OPRX
OptimizeRx
$4.89 $10.36 $90.1M -- $0.00 0% 1.01x
RHE
Regional Health Properties
$1.51 -- $2.8M 0.13x $0.00 0% 0.16x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ADUS
Addus HomeCare
-- 1.713 -- 2.03x
AMED
Amedisys
24.97% -0.159 11.88% 1.12x
DGX
Quest Diagnostics
47.86% -0.146 35.62% 1.02x
OPCH
Option Care Health
43.8% 2.260 20.87% 1.19x
OPRX
OptimizeRx
23.56% 4.188 24.93% 2.93x
RHE
Regional Health Properties
105.42% -0.982 206.21% 0.51x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ADUS
Addus HomeCare
$92.2M $26M 8.42% 9.24% 9.61% $46.6M
AMED
Amedisys
$250.1M $47M 5.39% 7.23% 6.26% $104M
DGX
Quest Diagnostics
$811M $330M 7.3% 12.68% 14.23% $250M
OPCH
Option Care Health
$256.7M $85.1M 8.33% 14.65% 6.72% $150.7M
OPRX
OptimizeRx
$13.4M -$1.1M -16.25% -20.12% -39.5% $1.7M
RHE
Regional Health Properties
$1.9M -$300K -5.98% -489.72% -7.22% -$147K

Addus HomeCare vs. Competitors

  • Which has Higher Returns ADUS or AMED?

    Amedisys has a net margin of 6.96% compared to Addus HomeCare's net margin of 2.88%. Addus HomeCare's return on equity of 9.24% beat Amedisys's return on equity of 7.23%.

    Company Gross Margin Earnings Per Share Invested Capital
    ADUS
    Addus HomeCare
    31.82% $1.10 $947.6M
    AMED
    Amedisys
    42.56% $0.51 $1.6B
  • What do Analysts Say About ADUS or AMED?

    Addus HomeCare has a consensus price target of $137.82, signalling upside risk potential of 4.89%. On the other hand Amedisys has an analysts' consensus of -- which suggests that it could grow by 14.02%. Given that Amedisys has higher upside potential than Addus HomeCare, analysts believe Amedisys is more attractive than Addus HomeCare.

    Company Buy Ratings Hold Ratings Sell Ratings
    ADUS
    Addus HomeCare
    8 0 0
    AMED
    Amedisys
    0 0 0
  • Is ADUS or AMED More Risky?

    Addus HomeCare has a beta of 1.015, which suggesting that the stock is 1.53% more volatile than S&P 500. In comparison Amedisys has a beta of 0.726, suggesting its less volatile than the S&P 500 by 27.385%.

  • Which is a Better Dividend Stock ADUS or AMED?

    Addus HomeCare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Amedisys offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Addus HomeCare pays -- of its earnings as a dividend. Amedisys pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ADUS or AMED?

    Addus HomeCare quarterly revenues are $289.8M, which are smaller than Amedisys quarterly revenues of $587.7M. Addus HomeCare's net income of $20.2M is higher than Amedisys's net income of $16.9M. Notably, Addus HomeCare's price-to-earnings ratio is 30.07x while Amedisys's PE ratio is 33.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Addus HomeCare is 1.95x versus 1.20x for Amedisys. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ADUS
    Addus HomeCare
    1.95x 30.07x $289.8M $20.2M
    AMED
    Amedisys
    1.20x 33.53x $587.7M $16.9M
  • Which has Higher Returns ADUS or DGX?

    Quest Diagnostics has a net margin of 6.96% compared to Addus HomeCare's net margin of 9.08%. Addus HomeCare's return on equity of 9.24% beat Quest Diagnostics's return on equity of 12.68%.

    Company Gross Margin Earnings Per Share Invested Capital
    ADUS
    Addus HomeCare
    31.82% $1.10 $947.6M
    DGX
    Quest Diagnostics
    32.6% $1.99 $13.2B
  • What do Analysts Say About ADUS or DGX?

    Addus HomeCare has a consensus price target of $137.82, signalling upside risk potential of 4.89%. On the other hand Quest Diagnostics has an analysts' consensus of $169.77 which suggests that it could grow by 10.89%. Given that Quest Diagnostics has higher upside potential than Addus HomeCare, analysts believe Quest Diagnostics is more attractive than Addus HomeCare.

    Company Buy Ratings Hold Ratings Sell Ratings
    ADUS
    Addus HomeCare
    8 0 0
    DGX
    Quest Diagnostics
    8 9 0
  • Is ADUS or DGX More Risky?

    Addus HomeCare has a beta of 1.015, which suggesting that the stock is 1.53% more volatile than S&P 500. In comparison Quest Diagnostics has a beta of 0.893, suggesting its less volatile than the S&P 500 by 10.74%.

  • Which is a Better Dividend Stock ADUS or DGX?

    Addus HomeCare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quest Diagnostics offers a yield of 1.93% to investors and pays a quarterly dividend of $0.75 per share. Addus HomeCare pays -- of its earnings as a dividend. Quest Diagnostics pays out 36.77% of its earnings as a dividend. Quest Diagnostics's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ADUS or DGX?

    Addus HomeCare quarterly revenues are $289.8M, which are smaller than Quest Diagnostics quarterly revenues of $2.5B. Addus HomeCare's net income of $20.2M is lower than Quest Diagnostics's net income of $226M. Notably, Addus HomeCare's price-to-earnings ratio is 30.07x while Quest Diagnostics's PE ratio is 20.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Addus HomeCare is 1.95x versus 1.80x for Quest Diagnostics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ADUS
    Addus HomeCare
    1.95x 30.07x $289.8M $20.2M
    DGX
    Quest Diagnostics
    1.80x 20.58x $2.5B $226M
  • Which has Higher Returns ADUS or OPCH?

    Option Care Health has a net margin of 6.96% compared to Addus HomeCare's net margin of 4.21%. Addus HomeCare's return on equity of 9.24% beat Option Care Health's return on equity of 14.65%.

    Company Gross Margin Earnings Per Share Invested Capital
    ADUS
    Addus HomeCare
    31.82% $1.10 $947.6M
    OPCH
    Option Care Health
    20.08% $0.31 $2.5B
  • What do Analysts Say About ADUS or OPCH?

    Addus HomeCare has a consensus price target of $137.82, signalling upside risk potential of 4.89%. On the other hand Option Care Health has an analysts' consensus of -- which suggests that it could grow by 31.43%. Given that Option Care Health has higher upside potential than Addus HomeCare, analysts believe Option Care Health is more attractive than Addus HomeCare.

    Company Buy Ratings Hold Ratings Sell Ratings
    ADUS
    Addus HomeCare
    8 0 0
    OPCH
    Option Care Health
    5 0 0
  • Is ADUS or OPCH More Risky?

    Addus HomeCare has a beta of 1.015, which suggesting that the stock is 1.53% more volatile than S&P 500. In comparison Option Care Health has a beta of 1.332, suggesting its more volatile than the S&P 500 by 33.16%.

  • Which is a Better Dividend Stock ADUS or OPCH?

    Addus HomeCare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Option Care Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Addus HomeCare pays -- of its earnings as a dividend. Option Care Health pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ADUS or OPCH?

    Addus HomeCare quarterly revenues are $289.8M, which are smaller than Option Care Health quarterly revenues of $1.3B. Addus HomeCare's net income of $20.2M is lower than Option Care Health's net income of $53.9M. Notably, Addus HomeCare's price-to-earnings ratio is 30.07x while Option Care Health's PE ratio is 19.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Addus HomeCare is 1.95x versus 0.84x for Option Care Health. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ADUS
    Addus HomeCare
    1.95x 30.07x $289.8M $20.2M
    OPCH
    Option Care Health
    0.84x 19.25x $1.3B $53.9M
  • Which has Higher Returns ADUS or OPRX?

    OptimizeRx has a net margin of 6.96% compared to Addus HomeCare's net margin of -42.82%. Addus HomeCare's return on equity of 9.24% beat OptimizeRx's return on equity of -20.12%.

    Company Gross Margin Earnings Per Share Invested Capital
    ADUS
    Addus HomeCare
    31.82% $1.10 $947.6M
    OPRX
    OptimizeRx
    63.11% -$0.50 $149.7M
  • What do Analysts Say About ADUS or OPRX?

    Addus HomeCare has a consensus price target of $137.82, signalling upside risk potential of 4.89%. On the other hand OptimizeRx has an analysts' consensus of $10.36 which suggests that it could grow by 111.8%. Given that OptimizeRx has higher upside potential than Addus HomeCare, analysts believe OptimizeRx is more attractive than Addus HomeCare.

    Company Buy Ratings Hold Ratings Sell Ratings
    ADUS
    Addus HomeCare
    8 0 0
    OPRX
    OptimizeRx
    4 1 0
  • Is ADUS or OPRX More Risky?

    Addus HomeCare has a beta of 1.015, which suggesting that the stock is 1.53% more volatile than S&P 500. In comparison OptimizeRx has a beta of 1.341, suggesting its more volatile than the S&P 500 by 34.097%.

  • Which is a Better Dividend Stock ADUS or OPRX?

    Addus HomeCare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OptimizeRx offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Addus HomeCare pays -- of its earnings as a dividend. OptimizeRx pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ADUS or OPRX?

    Addus HomeCare quarterly revenues are $289.8M, which are larger than OptimizeRx quarterly revenues of $21.3M. Addus HomeCare's net income of $20.2M is higher than OptimizeRx's net income of -$9.1M. Notably, Addus HomeCare's price-to-earnings ratio is 30.07x while OptimizeRx's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Addus HomeCare is 1.95x versus 1.01x for OptimizeRx. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ADUS
    Addus HomeCare
    1.95x 30.07x $289.8M $20.2M
    OPRX
    OptimizeRx
    1.01x -- $21.3M -$9.1M
  • Which has Higher Returns ADUS or RHE?

    Regional Health Properties has a net margin of 6.96% compared to Addus HomeCare's net margin of -23.24%. Addus HomeCare's return on equity of 9.24% beat Regional Health Properties's return on equity of -489.72%.

    Company Gross Margin Earnings Per Share Invested Capital
    ADUS
    Addus HomeCare
    31.82% $1.10 $947.6M
    RHE
    Regional Health Properties
    44.9% -$0.52 $43.9M
  • What do Analysts Say About ADUS or RHE?

    Addus HomeCare has a consensus price target of $137.82, signalling upside risk potential of 4.89%. On the other hand Regional Health Properties has an analysts' consensus of -- which suggests that it could grow by 330.46%. Given that Regional Health Properties has higher upside potential than Addus HomeCare, analysts believe Regional Health Properties is more attractive than Addus HomeCare.

    Company Buy Ratings Hold Ratings Sell Ratings
    ADUS
    Addus HomeCare
    8 0 0
    RHE
    Regional Health Properties
    0 0 0
  • Is ADUS or RHE More Risky?

    Addus HomeCare has a beta of 1.015, which suggesting that the stock is 1.53% more volatile than S&P 500. In comparison Regional Health Properties has a beta of 0.916, suggesting its less volatile than the S&P 500 by 8.446%.

  • Which is a Better Dividend Stock ADUS or RHE?

    Addus HomeCare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Regional Health Properties offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Addus HomeCare pays -- of its earnings as a dividend. Regional Health Properties pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ADUS or RHE?

    Addus HomeCare quarterly revenues are $289.8M, which are larger than Regional Health Properties quarterly revenues of $4.2M. Addus HomeCare's net income of $20.2M is higher than Regional Health Properties's net income of -$982K. Notably, Addus HomeCare's price-to-earnings ratio is 30.07x while Regional Health Properties's PE ratio is 0.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Addus HomeCare is 1.95x versus 0.16x for Regional Health Properties. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ADUS
    Addus HomeCare
    1.95x 30.07x $289.8M $20.2M
    RHE
    Regional Health Properties
    0.16x 0.13x $4.2M -$982K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 6.3% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 9.68% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.97% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock